Compounds > r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid
Page last updated: 2024-09-03

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and eprodisate

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with eprodisate in 1 studies

Compound Research Comparison

Studies
(r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid)		Trials
(r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid)		Recent Studies (post-2010)
(r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid)		Studies
(eprodisate)		Trials
(eprodisate)		Recent Studies (post-2010) (eprodisate)
17491325

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gironella-Mesa, M; Martínez-Valle, F; Solans-Laqué, R1

Reviews

1 review(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and eprodisate

ArticleYear
[New trends in the treatment of amyloidosis].
    Medicina clinica, 2012, May-26, Volume: 138, Issue:15

    Topics: Amyloid; Amyloidosis; Carboxylic Acids; Humans; Immunotherapy; Propane; Protein Conformation; Pyrrolidines; Sulfonic Acids

2012